8-K/A

AMENDMENT TO FORM 8-K

Company: Actinium Pharmaceuticals, Inc.
Filed: May 26, 2017
Period of Report: May 12, 2017
Accession Number: 0001213900-17-005912

View Document ↗ View on SEC.gov ↗